Adults 5 to 13, any sex, with Autism Spectrum Disorder or Mental Health Disorder. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Acceptability of Intervention MeasurePrimary· 6 months after starting implementation
The Acceptability of Intervention Measure (AIM) measure includes four items assessing the acceptability of an intervention. Participants rate the intervention using a 5-point Likert scale (1- Completely Disagree to 5- Completely Agree), with a minimum score of 4 and maximum score of 20 and higher scores indicating higher acceptability. This measure were designed to assess mental health providers' perceptions regarding acceptability of an evidence-based intervention. This measure demonstrate good reliability and validity. Providers trained in Unstuck and On Target completed this measure. Scores
Group
Value
95% CI
Therapists- Unstuck and On Target
4.58
± 0.46
Intervention Appropriateness MeasurePrimary· 6 months after starting implementation
The Intervention Appropriateness Measure (IAM) measure includes four items assessing the appropriateness of an intervention. Participants rate the intervention using a 5-point Likert scale (1- Completely Disagree to 5- Completely Agree), with a minimum score of 4 and maximum score of 20 and higher scores indicating higher appropriateness. This measure was designed to assess mental health providers' perceptions regarding appropriateness of an evidence-based intervention. This measure demonstrate good reliability and validity. Providers trained in Unstuck and On Target completed this measure. Sc
Group
Value
95% CI
Therapists - Unstuck and On Target
4.62
± 0.47
Feasibility of Intervention MeasurePrimary· 6 months after starting implementation
The Feasibility of Intervention Measure (FIM) measure includes 4 items assessing the feasibility of an intervention. Participants rate the intervention using a 5-point Likert scale (1- Completely Disagree to 5- Completely Agree), with a minimum score of 4 and maximum score of 20 and higher scores indicating higher feasibility. This measure was designed to assess mental health providers' perceptions regarding feasibility of an evidence-based intervention. This measure demonstrate good reliability and validity. Providers trained in Unstuck and On Target completed this measure. Scores are an over
Group
Value
95% CI
Therapists- Unstuck and On Target
4.5
± 0.61
Average of Provider Fidelity Throughout Implementation PeriodPrimary· A single, averaged value of all fidelity scores has been calculated. Average fidelity represents scores over the course of 6 months of therapist implementation. Table rows represent different aspects of fidelity that were scored.
Provider adherence or fidelity to the Unstuck and On Target intervention will be measured through observational coding of provider in-session behaviors using the fidelity measure developed as part of the Unstuck and On Target intervention. Observers rate the provider's use of Unstuck and On Target on 9 components, using a 5-point (1 to 5) Likert scale, with higher scores indicating higher fidelity.
For this report, a single, averaged value of all fidelity scores has been calculated per component.
Home Practice Review
Group
Value
95% CI
Usual Care
1.36
± 0.56
Unstuck and On Target
3.26
± 1.42
Content Delivery
Group
Value
95% CI
Usual Care
1.44
± 0.84
Unstuck and On Target
4.74
± 0.61
Use of Visuals
Group
Value
95% CI
Usual Care
2.10
± 1.13
Unstuck and On Target
4.64
± 0.66
Use of Handouts
Group
Value
95% CI
Usual Care
1.57
± 0.82
Unstuck and On Target
4.70
± 0.76
Use of Vocabulary
Group
Value
95% CI
Usual Care
1.75
± 1.00
Unstuck and On Target
4.47
± 0.67
Goal, Why, Plan, Do, Check
Group
Value
95% CI
Usual Care
1.25
± 0.77
Unstuck and On Target
4.18
± 1.05
Models Skills (Flexibility, planning)
Group
Value
95% CI
Usual Care
2.47
± 0.78
Unstuck and On Target
3.95
± 0.79
Use of More Positive Praise than Correction
Group
Value
95% CI
Usual Care
4.63
± 0.44
Unstuck and On Target
4.79
± 0.57
Child Behavior ChecklistPrimary· At baseline and 6 months post-implementation.
Child Behavior Checklist (CBCL) is a parent-report measure of child problem behavior. The CBCL is divided into three broadband scales (Internalizing, Externalizing, and Total Problem Scores) and several associate subscale scores. For this study, only the broadband scales were utilized for analyses. Scores are represented as T-scores with a population mean of 50 with standard deviation of 10 and ranges from 30 (minimum) to 95 (maximum. Higher scores reflect more mental health symptoms. The values reported below represent the mean change in the T-scores from the Total, Internalizing, and Externa
Change in Total Problem Score
Group
Value
95% CI
Usual Care: Children
-4.54
± 6.22
Unstuck and On Target: Children
-2.33
± 4.53
Change in Internalizing Behavior Score
Group
Value
95% CI
Usual Care: Children
-2.64
± 6.38
Unstuck and On Target: Children
-1.67
± 4.17
Change in Externalizing Behavior Score
Group
Value
95% CI
Usual Care: Children
-5.36
± 5.35
Unstuck and On Target: Children
-1.87
± 6.97
Eyberg Child Behavior InventorySecondary· At baseline and 6 months post-implementation.
The Eyberg Child Behavior Inventory is a 36 item questionnaire of child behavior. Caregivers of participating youth completed the questionnaire to assess their perceptions of their child's disruptive behaviors.
The Eyberg Child Behavior Inventory Intensity Scale score measures the frequency of a child's behavioral problems and ranges from 36 (minimum value) to 352 (maximum). A score of 127 or higher is considered to be in the clinical range.
The values reported below represent the mean change in the average T-score from baseline to 6 months post intervention for each condition group.
Negati
Group
Value
95% CI
Children- Usual Care
-7.09
± 8.47
Children- Unstuck and On Target
1.85
± 9.53
Wechsler Abbreviated Scale of Intelligence Second Edition- Block Design SubscaleSecondary· At baseline and 6 months post-implementation.
The Wechsler Abbreviated Scale of Intelligence Second Edition, is a brief measure of intelligence. We administered the Block Design subscale, a timed visual construction task that measures changes in nonverbal reasoning ability by assessing an individual's capacity to analyze and synthesize abstract visual stimuli, demonstrating visual-spatial skills, and coordinating visual perception with motor actions to replicate geometric patterns using colored blocks.The subtest is scored by converting the raw scores into scale scores using standardized norms. Scores range from 1 (minimum) to 19 (maximum
Group
Value
95% CI
Children- Usual Care
5.18
± 7.99
Children- Unstuck and On Target
.79
± 6.29
Executive Functioning Challenge TaskSecondary· At baseline and 6 months post-implementation.
The Executive Functioning Challenge Task deliberately tests a child's ability to utilize key executive functions like planning and flexibility by presenting scenarios that reveal potential areas of difficulty in their executive functioning skills. The test yields Flexibility and Planning raw scores with a minimum of 0 and maximum of 8. Higher scores indicate greater impairment in executive functioning. A total executive functioning raw score is also calculated as the sum of planning and flexibility scores.
Values below represent the change in average raw scores from baseline to post-intervent
Change in Planning Score
Group
Value
95% CI
Children- Usual Care
-0.09
± 1.81
Children- Unstuck and On Target
-2.21
± 1.97
Change in Flexibility Score
Group
Value
95% CI
Children- Usual Care
-.82
± 2.93
Children- Unstuck and On Target
-0.79
± 1.63
Change in Executive Functioning Total Score
Group
Value
95% CI
Children- Usual Care
-.91
± 4.01
Children- Unstuck and On Target
-3.00
± 2.80
Behavior Rating Inventory of Executive Function Second EditionSecondary· At baseline and 6 months post-implementation.
The Behavior Rating Inventory of Executive Function- Second Edition is a 63-item rating scale completed by caregivers to assess executive function impairment in children. T scores have a population mean of 50 and standard deviation of 10, with a minimum score of 30 and maximum score of 95. Scales assessed included the Behavioral Regulation Index, Emotion Regulation Index and Cognitive Regulation Index, together forming an overall composite score, the Global Executive Composite. Values below represent the change in T-scores scores from baseline to post-intervention for participating children. T
Change in Behavioral Regulation Index T-Score
Group
Value
95% CI
Children- Usual Care
-2.82
± 8.94
Children- Unstuck and On Target
-3.54
± 5.39
Change in Emotion Regulation Index T-Score
Group
Value
95% CI
Children- Usual Care
-2.82
± 10.42
Children- Unstuck and On Target
-0.31
± 6.96
Change in Cognitive Regulation Index T-Score
Group
Value
95% CI
Children- Usual Care
-1.55
± 7.09
Children- Unstuck and On Target
-2.62
± 7.68
Change in Global Executive Composite T-Score
Group
Value
95% CI
Children- Usual Care
-2.82
± 7.43
Children- Unstuck and On Target
-2.46
± 6.12
Adverse events — posted to ClinicalTrials.gov
Time frame: Adverse events data monitored throughout the 2 year study. Broader oversight for adverse events was provided by a Data Safety and Monitoring Committee (DSMB) selected before data collection began. The DSMB met repeatedly during the study at an average of 2 times a year through study completion (average of 4 meetings over the 2 year duration of the study)..
Reporting threshold: 0%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
Usual Care: Therapists
Serious: 0/18 (0%)
Deaths: 0/18
Unstuck and On Target: Therapists
Serious: 0/23 (0%)
Deaths: 0/23
Usual Care: Children
Serious: 0/12 (0%)
Deaths: 0/12
Unstuck and On Target: Children
Serious: 0/22 (0%)
Deaths: 0/22
Other adverse events (1 terms — click to expand)
Reaction
System
Usual Care: Therapists
Unstuck and On Target: The…
Usual Care: Children
Unstuck and On Target: Chi…
No Adverse Events were observed during the course of the study
The purpose of this project is to conduct a feasibility test of an ASD executive functioning intervention adapted for mental health settings, including examining the effectiveness and process of implementing this adapted intervention in community mental health programs.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Other recruiting trials for Autism Spectrum Disorder
Currently open trials in the same condition.
NCT07324057 — The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavi
· NA
· recruiting
NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor
· recruiting
NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f
· NA
· active not recruiting
NCT07524192 — A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Childre
· NA
· recruiting
NCT07432776 — Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
· EARLY_PHASE1
· recruiting
Other San Diego State University trials
Trials by the same sponsor.
NCT06900634 — Pilot of an Intervention to Reduce Alcohol Use and Improve ART Adherence Among Men Living With HIV With Pregnant Partner
· NA
· not yet recruiting
NCT07271290 — Preventing Noise Exposure in Farmworkers
· NA
· not yet recruiting
NCT07010133 — Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers (Aim 3)
· NA
· not yet recruiting
NCT06753123 — Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers (Aim 2)
· NA
· not yet recruiting
NCT06635642 — Auditory Research in Children Living With HIV Exposure-uninfected (ARCHIVE)
· NA
· withdrawn
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by San Diego State University
Last refreshed: 27 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04295512.